These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 20875790)

  • 1. Clonal cell populations unresponsive to radiosensitization induced by telomerase inhibition.
    Ju YJ; Shin HJ; Park JE; Juhn KM; Woo SR; Kim HY; Han YH; Hwang SG; Hong SH; Kang CM; Yoo YD; Park WB; Cho MH; Park GH; Lee KH
    Biochem Biophys Res Commun; 2010 Nov; 402(2):198-202. PubMed ID: 20875790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosomal end fusion resulting from telomere erosion increases susceptibility to radiation via multinucleation: effect of p53.
    Ju YJ; Park JE; Juhn KM; Jeong J; Yun M; Park MJ; Park GH; Choi KY; Cho MH; Wong KK; Park WB; Lee KH
    Int J Oncol; 2006 Oct; 29(4):753-63. PubMed ID: 16964373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomere length and radiosensitivity in human fibroblast clones immortalized by ectopic telomerase expression.
    Zongaro S; Verri A; Giulotto E; Mondello C
    Oncol Rep; 2008 Jun; 19(6):1605-9. PubMed ID: 18497972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ribozyme-mediated telomerase inhibition induces immediate cell loss but not telomere shortening in ovarian cancer cells.
    Saretzki G; Ludwig A; von Zglinicki T; Runnebaum IB
    Cancer Gene Ther; 2001 Oct; 8(10):827-34. PubMed ID: 11687906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomerase inhibition in RenCa, a murine tumor cell line with short telomeres, by overexpression of a dominant negative mTERT mutant, reveals fundamental differences in telomerase regulation between human and murine cells.
    Sachsinger J; González-Suárez E; Samper E; Heicappell R; Müller M; Blasco MA
    Cancer Res; 2001 Jul; 61(14):5580-6. PubMed ID: 11454711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous targeting of telomeres and telomerase as a cancer therapeutic approach.
    Mo Y; Gan Y; Song S; Johnston J; Xiao X; Wientjes MG; Au JL
    Cancer Res; 2003 Feb; 63(3):579-85. PubMed ID: 12566299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific telomere dysfunction induced by GRN163L increases radiation sensitivity in breast cancer cells.
    Gomez-Millan J; Goldblatt EM; Gryaznov SM; Mendonca MS; Herbert BS
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):897-905. PubMed ID: 17175117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomerase inhibition in a mouse cell line with long telomeres leads to rapid telomerase reactivation.
    Marie-Egyptienne DT; Brault ME; Zhu S; Autexier C
    Exp Cell Res; 2008 Feb; 314(3):668-75. PubMed ID: 18067891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal variation in phenotype and life span of human embryonic fibroblasts (MRC-5) transduced with the catalytic component of telomerase (hTERT).
    Franco S; MacKenzie KL; Dias S; Alvarez S; Rafii S; Moore MA
    Exp Cell Res; 2001 Aug; 268(1):14-25. PubMed ID: 11461114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen deficiency leads to telomerase inhibition, telomere shortening and reduced cell proliferation in the adrenal gland of mice.
    Bayne S; Jones ME; Li H; Pinto AR; Simpson ER; Liu JP
    Cell Res; 2008 Nov; 18(11):1141-50. PubMed ID: 18936784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomere erosion and chromosomal instability in cells expressing the HPV oncogene 16E6.
    Plug-DeMaggio AW; Sundsvold T; Wurscher MA; Koop JI; Klingelhutz AJ; McDougall JK
    Oncogene; 2004 Apr; 23(20):3561-71. PubMed ID: 15077181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomerase deletion limits progression of p53-mutant hepatocellular carcinoma with short telomeres in chronic liver disease.
    Lechel A; Holstege H; Begus Y; Schienke A; Kamino K; Lehmann U; Kubicka S; Schirmacher P; Jonkers J; Rudolph KL
    Gastroenterology; 2007 Apr; 132(4):1465-75. PubMed ID: 17433324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TP53-dependent chromosome instability is associated with transient reductions in telomere length in immortal telomerase-positive cell lines.
    Schwartz JL; Jordan R; Liber H; Murnane JP; Evans HH
    Genes Chromosomes Cancer; 2001 Mar; 30(3):236-44. PubMed ID: 11170280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrasting effects of telomere shortening on organ homeostasis, tumor suppression, and survival during chronic liver damage.
    Wiemann SU; Satyanarayana A; Buer J; Kamino K; Manns MP; Rudolph KL
    Oncogene; 2005 Feb; 24(9):1501-9. PubMed ID: 15608677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The level of telomere dysfunction determines the efficacy of telomerase-based therapeutics in a lung cancer cell line.
    Pantic M; Zimmermann S; Waller CF; Martens UM
    Int J Oncol; 2005 May; 26(5):1227-32. PubMed ID: 15809713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomere dynamics, end-to-end fusions and telomerase activation during the human fibroblast immortalization process.
    Ducray C; Pommier JP; Martins L; Boussin FD; Sabatier L
    Oncogene; 1999 Jul; 18(29):4211-23. PubMed ID: 10435634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tankyrase 1 as a target for telomere-directed molecular cancer therapeutics.
    Seimiya H; Muramatsu Y; Ohishi T; Tsuruo T
    Cancer Cell; 2005 Jan; 7(1):25-37. PubMed ID: 15652747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomere length mediates the effects of telomerase on the cellular response to genotoxic stress.
    Rubio MA; Davalos AR; Campisi J
    Exp Cell Res; 2004 Aug; 298(1):17-27. PubMed ID: 15242758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomere dysfunction and telomerase reactivation in human leukemia cell lines after telomerase inhibition by the expression of a dominant-negative hTERT mutant.
    Delhommeau F; Thierry A; Feneux D; Lauret E; Leclercq E; Courtier MH; Sainteny F; Vainchenker W; Bennaceur-Griscelli A
    Oncogene; 2002 Nov; 21(54):8262-71. PubMed ID: 12447689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomerase deficiency and telomere dysfunction inhibit mammary tumors induced by polyomavirus middle T oncogene.
    Jaskelioff M; Song W; Xia J; Liu C; Kramer J; Koido S; Gendler SJ; Calderwood SK; Gong J
    Oncogene; 2009 Dec; 28(48):4225-36. PubMed ID: 19734944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.